Table 1.
Baseline characteristics
| Variables | Total population (177) |
|---|---|
| Age, years | 80.8±7.7 |
| Logistic EuroSCORE (%) | 28.6±20.1 |
| Male, n (%) | 79 (44.6%) |
| BMI, kg/m2 | 24.7±6.2 |
| GFR<30 mL/min, n (%) | 41 (23.2%) |
| Anaemia,* n (%) | 91 (51.4%) |
| Dyslipidaemia, n (%) | 127 (71.8%) |
| COPD, n (%) | 47 (26.6%) |
| Diabetes, n (%) | 59 (33.3%) |
| Hypertension, n (%) | 150 (84.7%) |
| Previous AMI, n (%) | 40 (22.6%) |
| Atrial fibrillation, n (%) | 66 (37.3%) |
| Previous stroke, n (%) | 15 (8.5%) |
| PVD, n (%) | 79 (44.6%) |
| CAD, n (%) | 105 (59.3%) |
| Previous CABG, n (%) | 35 (19.8%) |
| Previous AVR, n (%) | 10 (5.6%) |
| Previous MVR, n (%) | 3 (1.7%) |
| PM, n (%) | 19 (10.7%) |
| Syncope, n (%) | 52 (29.4%) |
| Stable angina, n (%) | 66 (37.3%) |
| Unstable angina, n (%) | 12 (6.8%) |
| Cardiogenic shock, n (%) | 59 (33.3%) |
| NYHA class I or II, n (%) | 30 (17%) |
| NYHA class III or IV, n (%) | 147 (83%) |
| Recent PCI, n (%) | 24 (13.6%) |
Continuous variables are expressed as average±SD.
*Anaemia: cut-off Hb≤13 g/dL for male, Hb≤12 g/dL for female.
AMI, acute myocardial infarction; AVR, aortic valve replacement; BMI, body mass index; CABG, coronary artery bypass graft; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; EuroSCORE, European System for Cardiac Operative Risk Evaluation; GFR, glomerular filtration rate (based on Cockroft-Gault); MVR, mitral valve replacement; NYHA, New York Heart Association; PM, pacemaker; PVD, peripheral vascular disease; recent PCI, percutaneous coronary intervention <3 months before TAVI; TAVI, transcatheter aortic valve implantation.